Trial
NCT00651014
Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Organon and Co
Collaborators
Merck Frosst Canada Ltd.
Condition
Hypercholesterolemia
Intervention
Ezetimibe
Why stopped
slow subject recruitment and lack of medical and scientific merit due to change in new standard of therapy during that same period.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-17